Key result
Hyperlactatemia (≥4 mmol/L) during adult cardiac surgery under cardiopulmonary bypass was associated with a significantly higher risk of prolonged inotropic support (OR 5.66).
Why the study?
Does intraoperative hyperlactatemia (≥4 mmol/L) increase postoperative morbidity and mortality in adult patients undergoing elective cardiac surgery under cardiopulmonary bypass?
Population
370 adult patients undergoing elective cardiac surgery under cardiopulmonary bypass with ejection fraction…
Comparison
Intraoperative peak blood lactate levels ≥ 4.0… vs Intraoperative peak blood lactate levels < 4.0…
Design
Cohort
Follow-up
In-hospital
Authors
Loading...
May prompt closer monitoring of inotropic needs; hypothesis-generating and requires prospective validation.
Observational (n=370)
No
Does intraoperative hyperlactatemia (≥4 mmol/L) increase postoperative morbidity and mortality in adult patients undergoing elective cardiac surgery under cardiopulmonary bypass?
Odds Ratio: 5.66 (95% CI 3.06–10.48)
Absolute Event Rate: 34% vs 11.8%
p-value: p=0.001
Intraoperative hyperlactatemia (≥4 mmol/L) during cardiopulmonary bypass is a significant predictor of postoperative morbidity, including atrial fibrillation and prolonged inotrope requirement, highlighting the need for aggressive correction of inadequate tissue oxygen delivery.
Naik et al. (2016) conducted an observational in Adult patients undergoing elective cardiac surgery under cardiopulmonary bypass (n=370). Hyperlactatemia (serum lactate ≥4 mmol/L) vs. Serum lactate <4 mmol/L was evaluated on Prolonged requirement of inotropes (OR 5.66, 95% CI 3.06-10.48, p=0.001). Hyperlactatemia (≥4 mmol/L) during adult cardiac surgery under cardiopulmonary bypass was associated with a significantly higher risk of prolonged inotropic support (OR 5.66).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: